Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rosing

Showing results (81-90 of 142) with videos related to

Pageof 15
Sort By:
The Journal of Biological Chemistry|January 10, 1980
The role of phospholipids and factor Va in the prothrombinase complexJ Rosing, G Tans, J W Govers-Riemslag, et al.
Journal of Thrombosis and Haemostasis : JTH|November 23, 2006
The risk of venous thrombosis associated with a high endogenous thrombin potential in the absence and presence of activated protein CA Brandts, A van Hylckama Vlieg, J Rosing, et al.
Thrombosis and Haemostasis|February 24, 2001
Functional properties of factor V and factor Va encoded by the R2-geneL Hoekema, E Castoldi, G Tans, et al.
Journal of Thrombosis and Haemostasis : JTH|November 3, 2011
Genetic modulation of the FV(Leiden)/normal FV ratio and risk of venous thrombosis in factor V Leiden heterozygotesO Segers, P Simioni, D Tormene, et al.
Thrombosis Research|October 11, 2021
Resistance to activated protein C and impaired TFPI activity in women with previous hormone-induced venous thromboembolismS N Tchaikovski, M C L G D Thomassen, E Stickeler, et al.
Journal of Thrombosis and Haemostasis : JTH|February 16, 2013
Resistance to APC and SHBG levels during use of a four-phasic oral contraceptive containing dienogest and estradiol valerate: a randomized controlled trialM Raps, F Rosendaal, B Ballieux, et al.
Biophysical Journal|December 26, 2003
Theoretical and experimental study of the D2194G mutation in the C2 domain of coagulation factor VM A Miteva, J M Brugge, J Rosing, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 13, 2001
Activated protein C resistance during in vitro fertilization treatmentJ Curvers, S J Nienhuis, A W Nap, et al.
Biochemistry|November 23, 2000
C4b-binding protein protects coagulation factor Va from inactivation by activated protein CR H van de Poel, J C Meijers, J Rosing, et al.
Biochemistry|October 26, 1982
Factor Va-factor Xa interaction. Effects of phospholipid vesicles of varying compositionT Lindhout, J W Govers-Riemslag, P van de Waart, et al.
Pageof 15

Showing results (81-90 of 142) with videos related to

Sort By:
Pageof 15
The Journal of Biological Chemistry|January 10, 1980
The role of phospholipids and factor Va in the prothrombinase complexJ Rosing, G Tans, J W Govers-Riemslag, et al.
Journal of Thrombosis and Haemostasis : JTH|November 23, 2006
The risk of venous thrombosis associated with a high endogenous thrombin potential in the absence and presence of activated protein CA Brandts, A van Hylckama Vlieg, J Rosing, et al.
Thrombosis and Haemostasis|February 24, 2001
Functional properties of factor V and factor Va encoded by the R2-geneL Hoekema, E Castoldi, G Tans, et al.
Journal of Thrombosis and Haemostasis : JTH|November 3, 2011
Genetic modulation of the FV(Leiden)/normal FV ratio and risk of venous thrombosis in factor V Leiden heterozygotesO Segers, P Simioni, D Tormene, et al.
Thrombosis Research|October 11, 2021
Resistance to activated protein C and impaired TFPI activity in women with previous hormone-induced venous thromboembolismS N Tchaikovski, M C L G D Thomassen, E Stickeler, et al.
Journal of Thrombosis and Haemostasis : JTH|February 16, 2013
Resistance to APC and SHBG levels during use of a four-phasic oral contraceptive containing dienogest and estradiol valerate: a randomized controlled trialM Raps, F Rosendaal, B Ballieux, et al.
Biophysical Journal|December 26, 2003
Theoretical and experimental study of the D2194G mutation in the C2 domain of coagulation factor VM A Miteva, J M Brugge, J Rosing, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 13, 2001
Activated protein C resistance during in vitro fertilization treatmentJ Curvers, S J Nienhuis, A W Nap, et al.
Biochemistry|November 23, 2000
C4b-binding protein protects coagulation factor Va from inactivation by activated protein CR H van de Poel, J C Meijers, J Rosing, et al.
Biochemistry|October 26, 1982
Factor Va-factor Xa interaction. Effects of phospholipid vesicles of varying compositionT Lindhout, J W Govers-Riemslag, P van de Waart, et al.
Pageof 15